Losartan Potassium
Product Images NDC 53002-5624

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-5624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530025624)

FDA Label Image

Figure1 (Losartan Fig1)

Figure1 (Losartan Fig1)
This appears to be a graph or chart of some sort, showing the adjusted risk reduction percentages for Atenolol and Losartan Potassium over a period of 66 study months. Due to the lack of additional information, it is not possible to provide more context or details about the study or its findings.*
FDA Label Image

Figure2 (Losartan Fig2)

FDA Label Image

Figure 3 (Losartan Fig3)

Figure 3 (Losartan Fig3)
This appears to be a table or a figure depicting primary endpoint events within different demographic subgroups, showing results for age, gender, race, and other factors. The specific details of the results cannot be determined due to the unclear text.*
FDA Label Image

Figure-4 (Losartan Fig4)

Figure-4 (Losartan Fig4)
This is a statistical representation of an event in a study evaluating the effectiveness of Losartan Potassium compared to a placebo. The text indicates that out of the patients involved, 60% had an event in the Losartan group, while 40% had an event in the placebo group. The risk reduction was found to be 16.1% with a p-value of 0.022.*
FDA Label Image

Chemical Structure (Losartan Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.